PATENT CLAIM ANALYSIS

Application Number: 16131512
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "044000"]

Abstract:
Antisense sequences, including duplex RNAi compositions, which possess improved properties over those taught in the prior art are disclosed. The invention provides optimized antisense oligomer compositions and method for making and using the both in in vitro systems and therapeutically. The invention also provides methods of making and using the improved antisense oligomer compositions.

Claim (Index 17):
The composition of  claim 15  wherein the target nucleic acid is a mRNA and the at least one strand comprising a 2\u2032-O-methyl modification is an antisense strand.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.51282
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15418653', '14446022', '13277957', '15638586', '13147882']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7521607994459908
- 35 USC 102 Novelty (BERT): 0.5829572748491174
- Combined Prediction Score: 0.7352404469863034
- Mean Citation Score: 437.96879
- Max Citation Score: 530.86646
- Similarity Product: 405.41107566191664

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test